Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Cancer Imaging and Image-directed Interventions

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1619341

This article is part of the Research TopicRadiomics and Artificial Intelligence in Oncology ImagingView all 8 articles

Multi-model Radiomics and Machine Learning for Differentiating Lipid-Poor Adrenal Adenomas from Metastases Using Automatic Segmentation

Provisionally accepted
Shengnan  YinShengnan YinNing  DingNing DingMengjuan  LiMengjuan LiYichi  ZhangYichi ZhangJiacheng  ShenJiacheng ShenHaitao  HuHaitao HuYiding  JiYiding Ji*Long  JinLong Jin*
  • Suzhou Ninth People's Hospital, Suzhou, China

The final, formatted version of the article will be published soon.

Background Radiomics based on automatic segmentation of CT images has emerged as a highly promising approach for differentiating adrenal adenomas from metastases; however, its preoperative diagnostic value has not been fully evaluated in previously developed methodologies.Objective To fully elucidate the diagnostic value of radiomics based on automatic segmentation techniques in differentiating adrenal adenomas from metastases through a retrospective analysis of clinical and contrast-enhanced CT (CECT) data.Methods A retrospective analysis was conducted on the clinical and imaging data of 416 patients with adrenal masses larger than 10 mm, who had clinically indicated contrast-enhanced CT (CECT) examinations at our hospital between January 2020 and June 2024. Adrenal lesions were segmented automatically using 3D Slicer, and radiomic features were extracted from the segmented arterial and venous phase images using PyRadiomics. Feature selection and dimensionality reduction were performed using mutual information (MI), minimum redundancy maximum relevance (MRMR), LASSO, and Pearson correlation analysis. Clinical and imaging features were then incorporated into an XGBoost machine learning model, and model performance was evaluated using Area Under Curve (AUC), accuracy, precision, sensitivity, specificity, and F1 score. SHAP analysis was used to interpret the model's predictions and identify the most influential features.This study included 221 adenomas and 195 metastases. Significant differences were observed between the two groups in terms of age, lesion size, and contrast washout rate (P < 0.001). After feature extraction, selection, and dimensionality reduction, 15 arterial phase features, 6 venous phase features, and 18 combined features were used for model training. The AUC values of the XGBoost model for the arterial phase, venous phase, combined arterial and venous phase data, and combined arterial, venous phase, and clinical indicators were 0.81, 0.81, 0.88, and 0.92, respectively. Five-fold crossvalidation showed that the average scores of XGBoost were 0.868, 0.823, 0.897, and 0.89, respectively. SHAP summary plot for each sample under different features were used to illustrate the interpretability of the model.A machine learning model, combining multimodal CT radiomics and automatic segmentation technology, enables machine-based clinical features extraction, improves the differentiation between adrenal adenomas and metastases, and provides a reliable foundation for accurate diagnosis and treatment planning.

Keywords: Adrenal masses, Radiomics, Contrast-enhanced CT, machine learning, SHAP analysis

Received: 28 Apr 2025; Accepted: 30 Jun 2025.

Copyright: © 2025 Yin, Ding, Li, Zhang, Shen, Hu, Ji and Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yiding Ji, Suzhou Ninth People's Hospital, Suzhou, China
Long Jin, Suzhou Ninth People's Hospital, Suzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.